|
Volumn 105, Issue 20, 2002, Pages 2435-2441
|
Cellular cardiomyoplasty improves survival after myocardial injury
a b b b a b b b,d c b c d b b a b b
c
Pluriomics BV
(Germany)
|
Author keywords
Cells; Contractility; Electrophysiology; Survival; Transplantation
|
Indexed keywords
GREEN FLUORESCENT PROTEIN;
ANIMAL CELL;
ANIMAL MODEL;
ARTICLE;
CARDIOMYOPLASTY;
CELL SURVIVAL;
CELL TRANSPLANTATION;
CONTROLLED STUDY;
ECHOCARDIOGRAPHY;
EMBRYO;
HEART ELECTROPHYSIOLOGY;
HEART FAILURE;
HEART MUSCLE CELL;
HEART MUSCLE CONTRACTILITY;
HEART VENTRICLE WALL;
IMMUNOHISTOCHEMISTRY;
MALE;
MOUSE;
MUSCLE FORCE;
MUSCLE ISOMETRIC CONTRACTION;
NONHUMAN;
PRIORITY JOURNAL;
ANIMALS;
BLOTTING, WESTERN;
CARDIOMYOPLASTY;
CELL DIFFERENTIATION;
CELL SURVIVAL;
CELL TRANSPLANTATION;
DISEASE MODELS, ANIMAL;
ECHOCARDIOGRAPHY;
ELECTROPHYSIOLOGY;
FETAL TISSUE TRANSPLANTATION;
GENES, REPORTER;
GRAFT SURVIVAL;
HEART FUNCTION TESTS;
MALE;
MICE;
MICE, INBRED C57BL;
MICE, TRANSGENIC;
MYOCARDIAL CONTRACTION;
MYOCARDIAL INFARCTION;
MYOCARDIUM;
SURVIVAL RATE;
TREATMENT OUTCOME;
VENTRICULAR DYSFUNCTION, LEFT;
|
EID: 0037150159
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/01.CIR.0000016063.66513.BB Document Type: Article |
Times cited : (126)
|
References (24)
|